MME and Alzheimer disease: Previously, we identified Neprilysin (NEP; neutral endopeptidase 24.11) as a major physiological Aβ-degrading enzyme in brain [5, 6], the expression and activity of which in brain decline with aging and in early stages of AD progression [7–10].